Vanguard Personalized Indexing Management, LLC Allogene Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.09 Billion
- Q3 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 15,797 shares of ALLO stock, worth $42,967. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,797
Previous 10,399
51.91%
Holding current value
$42,967
Previous $24,000
83.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALLO
# of Institutions
170Shares Held
132MCall Options Held
94.3KPut Options Held
112K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$50.9 Million1.08% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$44.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$22.7 Million0.0% of portfolio
-
State Street Corp Boston, MA7.01MShares$19.1 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA6.9MShares$18.8 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $391M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...